These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 9772924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.
    Cochrane Database Syst Rev; 2014 Apr 20; 2014(4):CD010189. PubMed ID: 24748537
    [Abstract] [Full Text] [Related]

  • 3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 20; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 4. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE, Hutchinson RJ, DebRoy M, Magee JC.
    Pediatr Transplant; 2004 Oct 20; 8(5):507-12. PubMed ID: 15367289
    [Abstract] [Full Text] [Related]

  • 5. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA, Ildstad ST.
    Hum Immunol; 1997 Feb 20; 52(2):155-61. PubMed ID: 9077564
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec 20; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 7. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.
    Biol Blood Marrow Transplant; 2003 Jan 20; 9(1):52-9. PubMed ID: 12533742
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 20; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 10. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression.
    Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP.
    Clin Transplant; 1999 Aug 20; 13(4):330-5. PubMed ID: 10485375
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver.
    Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW.
    Liver Transpl Surg; 1996 May 20; 2(3):225-32. PubMed ID: 9346652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E, Hatz C, Jonker EF, Visser LG, Jaeger VK, Bühler S.
    Vaccine; 2017 Mar 01; 35(9):1216-1226. PubMed ID: 28162821
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC, McGuire TR.
    Clin Pharm; 1985 Mar 01; 4(2):149-60. PubMed ID: 3886273
    [Abstract] [Full Text] [Related]

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 18. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Robertson MJ, Spector N, Gonin R.
    J Clin Oncol; 1992 Jul 01; 10(7):1191-200. PubMed ID: 1607923
    [Abstract] [Full Text] [Related]

  • 19. Unrelated donor bone marrow transplants in children.
    Grovas A, Feig SA, O'Rourke S, Valentino L, Wiley F, Hunt L, Landaw EM, Gajewski J.
    Cell Transplant; 1994 Jul 01; 3(5):413-20. PubMed ID: 7827779
    [Abstract] [Full Text] [Related]

  • 20. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):549-54. PubMed ID: 8722353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.